Actively Recruiting
Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
Led by University Hospital, Strasbourg, France · Updated on 2025-12-23
30
Participants Needed
1
Research Sites
55 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prevention).
CONDITIONS
Official Title
Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult (≥18 years)
- Immunocompromised (i.e., solid organ transplant recipient, hematological malignancy, cancer patient, patient treated with immunosuppressive therapy or therapy affecting the immune system by any mechanism, hematopoietic stem cell transplant recipient, patient with an autoimmune disease or immunodeficiency, whether primary or secondary).
- At least one positive toxoplasmosis PCR test (regardless of tissue)
You will not qualify if you...
- Subject who has expressed opposition to the reuse of their data for scientific research.
- HIV positive
- Congenital toxoplasmosis
- Isolated ocular toxoplasmosis in immunocompetent individuals
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service d'immunologie clinique - Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091
Actively Recruiting
Research Team
M
Mathilde HERBER, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here